04/23/2024
3:06 PM | Stoke Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024
3:08 PM | Stoke Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024
3:11 PM | Stoke Therapeutics (Filer)
| Form ARS | |
04/18/2024
3:16 PM | Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
3:18 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13D/A | |
04/17/2024
3:17 PM | Ezbon International Ltd (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
3:06 PM | Stoke Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
04/03/2024
3:19 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:36 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
4:20 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
3:47 PM | Stoke Therapeutics (Filer)
| Form 424B5 | |
03/25/2024
3:03 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:07 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:07 PM | Stoke Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2024
7:29 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:30 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:31 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:34 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:36 PM | Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
9:36 AM | Cowen Financial Products LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G | |
02/26/2024
9:38 AM | Cowen Financial Products LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/15/2024
3:17 PM | Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:20 AM | Lynx1 Capital Management LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
6:44 AM | RTW INVESTMENTS, LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
1:51 PM | MORGAN STANLEY (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024
3:32 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:49 PM | Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:09 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
3:15 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:17 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:18 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:20 PM | Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
8:04 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
3:37 PM | Stoke Therapeutics (Subject)
| Form SC TO-I/A | |
11/07/2023
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
8:01 AM | Stoke Therapeutics (Subject)
| Form SC TO-I | |
10/26/2023
4:00 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
3:44 PM | SMITH IAN F (Reporting)
Stoke Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/20/2023
3:48 PM | SMITH IAN F (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:37 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
War Over Taiwan? Protect Your Wealth NOW (Ad) With tensions rapidly escalating, Taiwan could provide the spark at any moment.
Don't let your financial future get caught in the crossfire unprepared. Access my report now >>> |
09/18/2023
3:05 PM | Stoke Therapeutics (Filer)
| Form PRE 14A | |
09/08/2023
3:15 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2023
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
4:20 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:45 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:18 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
5:24 PM | LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:25 PM | Menzel Garry E (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:26 PM | Smith Julie (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:26 PM | Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:22 PM | Burstein Jennifer (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:23 PM | Harrison Seth Loring (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:24 PM | Krainer Adrian R. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
6:31 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:15 PM | Stoke Therapeutics (Filer)
| Form DEFA14A | |
05/08/2023
6:35 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
3:06 PM | Stoke Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
7:04 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
3:43 PM | Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
